MSB 3.19% 97.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-864

  1. 1,949 Posts.
    lightbulb Created with Sketch. 696
    A timing question of FDA response and the PDUFA date that has been bugging me.

    In the past it has taken the FDA/MSB nearly two months to respond and to the BLA submission and announce the PDUFA date. That is noted from past posts by Reg I believe.

    Soooo…..

    If the review time needed by the FDA is only 2 months for this BLA submission - are the FDA simply going to respond after nearly two months and say approved rather than issue a PDUFA date!

    or are the FDA going to change their PDUFA timing response to MSB to be a lesser time this time around, like after 3 weeks a response from the FDA to set a 2 Month time frame.

    If 6 months obviously situation is just repeated like last two times - that is known.

    Interested to know thoughts on timings on FDA/MSB announcements for 2 month review.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.030(3.19%)
Mkt cap ! $1.107B
Open High Low Value Volume
94.0¢ 98.0¢ 92.0¢ $3.342M 3.477M

Buyers (Bids)

No. Vol. Price($)
4 33313 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 73982 2
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.